StockData
Sight Sciences, Inc. logo

Sight Sciences, Inc. (SGHT) stock

SGHTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30174% above fair value
$10.77+0.28 (+2.67%)

Close on Nov 18, 2026Market cap $593.30MP/E –Yield –

Sight Sciences operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Sight Sciences's operating income for the twelve months ending Jun 30, 2026 was -$27.88M. For fiscal 2025 it was -$37.10M. The highest annual figure on record is -$32.19M in fiscal 2020.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$37.10M–
FY2024Dec 31, 2024-$50.53M–
FY2023Dec 31, 2023-$57.27M–
FY2022Dec 31, 2022-$83.95M–
FY2021Dec 31, 2021-$51.48M–
FY2020Dec 31, 2020-$32.19M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.89M–
Q1 FY2026Mar 31, 2026-$12.41M–
Q4 FY2025Dec 31, 2025-$3.67M–
Q3 FY2025Sep 30, 2025-$7.91M–
Q2 FY2025Jun 30, 2025-$11.67M–
Q1 FY2025Mar 31, 2025-$13.86M–
Q4 FY2024Dec 31, 2024-$11.93M–
Q3 FY2024Sep 30, 2024-$11.23M–
Q2 FY2024Jun 30, 2024-$12.65M–
Q1 FY2024Mar 31, 2024-$14.72M–
Q4 FY2023Dec 31, 2023-$11.11M–
Q3 FY2023Sep 30, 2023-$13.41M–
Q2 FY2023Jun 30, 2023-$15.19M–
Q1 FY2023Mar 31, 2023-$17.57M–
Q4 FY2022Dec 31, 2022-$17.05M–
Q3 FY2022Sep 30, 2022-$21.85M–
Q2 FY2022Jun 30, 2022-$22.86M–
Q1 FY2022Mar 31, 2022-$22.19M–
Q4 FY2021Dec 31, 2021-$14.72M–
Q3 FY2021Sep 30, 2021-$14.03M–
Q2 FY2021Jun 30, 2021-$11.08M–
Q1 FY2021Mar 31, 2021-$11.66M–
Q4 FY2020Dec 31, 2020-$8.43M–
Q3 FY2020Sep 30, 2020-$7.36M–
Q2 FY2020Jun 30, 2020-$7.69M–

More Sight Sciences figures

See a number that looks wrong?